Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Merit Medical Anticipates Cook Medical Deal To Be Modestly Dilutive To Full-year 2024 Non-GAAP Profitability Given Partial-year Contribution

Author: Benzinga Newsdesk | September 17, 2024 07:08am

Lampropoulos continued: "We have updated our full-year 2024 financial guidance to include the projected impact of this acquisition from a prospective closing date of October 31, 2024 to December 31, 2024 and, importantly, we have reaffirmed our updated full-year 2024 financial guidance previously issued on August 1, 2024."

"We look forward to discussing this acquisition and our updated outlook for 2024 on our third quarter earnings report on October 30, 2024."

Posted In: MMSI

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist